Reports for TEVA CANADA LIMITED

Company Name

TEVA CANADA LIMITED

Totals

Shortage reports

2654

Actual shortage: 249 (9%)
Anticipated shortage: 0 (0%)
Avoided shortage: 9 (0%)
Resolved: 2396 (90%)

Discontinuation Reports

250

To be discontinued: 3 (1%)
Discontinued: 247 (99%)
Reversed: 0 (0%)

Late reports

329 (11%)

Overdue reports

26 (10%)

Shortage reports
Brand name Strength Dosage Status Date Created Date Updated Reports
TEVA-TADALAFIL 5MG TABLET Resolved 2024-03-28 2024-04-25 223859
TEVA-TELMISARTAN 80MG TABLET Resolved 2024-01-11 2024-04-25 215728
TEVA-TELMISARTAN 40MG TABLET Resolved 2023-07-20 2024-04-25 199393
TEVA-FLUVASTATIN 20MG CAPSULE Resolved 2023-11-03 2024-04-25 209111
TEVA-BETAHISTINE 24MG TABLET Resolved 2024-02-01 2024-04-25 218129
TEVA-OLANZAPINE 5MG TABLET Resolved 2024-03-28 2024-04-25 223844
TEVA-SERTRALINE 100MG CAPSULE Resolved 2024-03-21 2024-04-25 222938
TEVA-NAPROXEN 500MG TABLET Resolved 2024-02-01 2024-04-25 218123
TEVA-CEPHALEXIN 250 250MG POWDER FOR SUSPENSION Resolved 2023-08-03 2024-04-25 200864
ACT DEXTROAMPHETAMINE SR 15MG CAPSULE (SUSTAINED-RELEASE) Resolved 2024-01-25 2024-04-25 217240
ACT DEXTROAMPHETAMINE SR 10MG CAPSULE (SUSTAINED-RELEASE) Resolved 2024-02-01 2024-04-25 218145
TEVA-TADALAFIL 2.5MG TABLET Actual shortage 2024-04-25 2024-04-25 226177
TEVA-BUSPIRONE 10MG TABLET Actual shortage 2024-04-25 2024-04-25 226174
TEVA-ECTOSONE 0.1% LOTION Actual shortage 2024-04-25 2024-04-25 226171
TEVA-MOMETASONE 50MCG SPRAY, METERED DOSE Actual shortage 2024-01-11 2024-04-25 215760
TEVA-DULOXETINE 30MG CAPSULE (DELAYED RELEASE) Actual shortage 2024-01-11 2024-04-25 215751
TEVA-BUPRENORPHINE/NALOXONE 2MG 0.5MG TABLET Actual shortage 2024-03-07 2024-04-25 221534
ACT METHYLPHENIDATE ER 18MG TABLET (EXTENDED-RELEASE) Actual shortage 2024-03-28 2024-04-25 223862
TEVA-BUPROPION XL 300MG TABLET (EXTENDED-RELEASE) Actual shortage 2024-04-05 2024-04-25 224445
TEVA-DILTIAZEM XC 360MG TABLET (EXTENDED-RELEASE) Actual shortage 2024-03-07 2024-04-25 221546

Showing 1 to 20 of 2654

Discontinuation reports
Brand name Strength Dosage Status Date Created Date Updated Reports
TEVA-IRBESARTAN 75MG TABLET Discontinued 2024-04-01 2024-04-01 224049
TEVA-DICLOFENAC EC 25MG TABLET (ENTERIC-COATED) Discontinued 2024-01-25 2024-01-26 217254
TEVA-ECTOSONE 0.1% LOTION Discontinued 2023-12-05 2023-12-05 212526
CEFAZOLIN FOR INJECTION 10G POWDER FOR SOLUTION Discontinued 2023-11-27 2023-11-27 211558
PIPERACILLIN / TAZOBACTAM POWDER FOR INJECTION 0.5G 4G POWDER FOR SOLUTION Discontinued 2023-11-15 2023-11-15 210194
PIPERACILLIN / TAZOBACTAM POWDER FOR INJECTION 0.375G 3G POWDER FOR SOLUTION Discontinued 2023-11-15 2023-11-15 210191
TEVA-ROSUVASTATIN 5MG TABLET Discontinued 2022-03-25 2022-03-26 157428
TEVA-ROSUVASTATIN 10MG TABLET Discontinued 2022-03-25 2022-03-26 157431
TEVA-ROSUVASTATIN 20MG TABLET Discontinued 2022-03-25 2022-03-26 157434
TEVA-ROSUVASTATIN 40MG TABLET Discontinued 2022-03-25 2022-03-26 157437
TEVA-AMITRIPTYLINE 50MG TABLET Discontinued 2022-01-07 2022-01-07 152378
TEVA-AMITRIPTYLINE 25MG TABLET Discontinued 2022-01-07 2022-01-07 152375
TEVA-AMITRIPTYLINE 25MG TABLET Discontinued 2022-01-07 2022-01-07 152351
ACT NABILONE 0.5MG CAPSULE Discontinued 2021-09-23 2021-09-23 146066
METHYLPREDNISOLONE SODIUM SUCCINATE FOR INJECTION 40MG POWDER FOR SOLUTION Discontinued 2021-09-23 2021-09-23 146061
ACT DILTIAZEM CD 180MG CAPSULE (EXTENDED RELEASE) Discontinued 2021-07-22 2021-07-22 142921
ACT DILTIAZEM CD 300MG CAPSULE (EXTENDED RELEASE) Discontinued 2021-07-22 2021-07-22 142918
ACT DILTIAZEM CD 120MG CAPSULE (EXTENDED RELEASE) Discontinued 2021-07-22 2021-07-22 142915
ACT RIZATRIPTAN 10MG TABLET Discontinued 2021-07-22 2021-07-22 142912
TEVA-MIRTAZAPINE 30MG TABLET Discontinued 2021-02-12 2021-02-12 133908

Showing 1 to 20 of 250